Clinical Trials Cold Chain Logistic Services Market to Reach USD 4 Billion by 2018

February 04 20:45 2014
With both pharmaceutical and biological manufacturers globalizing their clinical trials, the demand for efficient packaging, storage and transportation services of clinical trial materials is expected to witness strong growth in the coming years.

Dwindling drug pipelines, increasing trends in clinical research outsourcing, rising commercial presence in global markets and an increasing preference of manufacturers to invest in biologicals compared to small molecule drugs are expected to be the key factors driving the market for cold chain clinical trials logistic services in the coming years. Research firm IMARC Group expects this market to reach revenues worth nearly USD 4 Billion by 2018, according to its latest report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2013-2018)”. 

The report which has done a comprehensive analysis on the market for cold chain healthcare logistic services expects pharmaceutical and biological manufacturers to increase the globalization of their clinical trials in order to expand their markets. According to an analyst at IMARC Group, “In order to expand their revenues, global pharmaceutical and biotech companies are looking towards increasing their customer base from their core markets (US and Western European countries) to other regions around the world. In order to launch drugs in certain countries such as Japan, regulatory agencies make it mandatory for companies to conduct clinical trials in that country. This is expected to create a huge demand for efficient packaging, storage and transportation of clinical trials materials between different regions”.

The report provides market analysis, information and insights into the global clinical trials cold chain logistic services market. This includes:

  • Introduction and insights into the global clinical trials cold chain logistic services market
  • Current, historical and future sales performance
  • Logistic requirements for clinical trial materials
  • Impact of temperature excursions
  • Opportunities
  • Costs involved

This market research report attempts to provide insights to senior and top-level executives, on decisive industry questions on the global healthcare cold chain logistic services market such as the current and expected trends, market performance, business models, opportunities, drivers, challenges, cold chain requirements for various products, impact of temperature excursions, costs involved, etc. The report, which is the third edition of our highly acclaimed publication, draws upon a comprehensive analysis on the global healthcare cold chain logistic services market.

Table of Contents

1 Research Methodology & Market Definitions
2 Executive Summary
3 The Global Healthcare Cold Chain Logistics Market
3.1 Current Trends
3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 The Global Healthcare Cold Chain Products Market
4.1 Current Market Trends & Forecast
4.2 Market Segments
4.2.1 Biopharmaceuticals
4.2.1.1 Current Market Trends & Forecast
4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
4.2.2 Vaccines
4.2.2.1 Current Market Trends & Forecast
4.2.2.2 Cold Chain Requirements for Vaccines
4.2.2.3 Cold Chain Opportunities for Vaccines
4.2.3 Clinical Trial Materials
4.2.3.1 Current Market Trends & Forecast
4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
5 Healthcare Cold Chain Logistics: How Does It Operate?
5.1 Cold Chain Packaging & Transportation Methods
5.1.1 Dry Ice
5.1.2 Liquid Nitrogen
5.1.3 Gel Packs
5.2 Modelling the Cost of Cold Chain Packaging & Transportation
5.3 Setting Up a Cold Chain
5.3.1 Initial Considerations
5.3.2 Choosing the Correct Model
5.3.3 Regulatory/Custom Clearance
5.3.4 Final Stages
5.3.5 Quality Assurance
6 The Healthcare Cold Chain Logistic Services Market
6.1 Current Market Trends
6.2 Market Forecast
6.3 Market Segmentation
6.3.1 Market by Product
6.3.1.1 Biopharmaceuticals & Vaccines
6.3.1.2 Clinical Trial Materials
6.3.2 Market by Segment
6.3.2.1 Packaging & Instrumentation
6.3.2.2 Transportation
6.3.3 Market by Region
6.3.3.1 North America
6.3.3.2 Europe
6.3.3.3 Asia Pacific
6.3.3.4 Rest of the World
7 Challenges in the Healthcare Cold Chain Logistics Market
7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
7.3 New Technologies Nullifying the Need of Cold Chains
8 Key Company Profiles
8.1 World Courier
8.2 DHL
8.3 Fedex
8.4 United Parcel Service
8.5 Kuehne and Nagel
8.6 Cavalier Logistics
8.7 DB Schenker
8.8 Life ConEx
8.9 American Airlines Cargo
8.10 Continental Air Cargo
8.11 Marken

List of Figures

Figure 3 1: Global – Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2005 – 2012
Figure 3 2: Global – Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2013 – 2018
Figure 3 3: Global – Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
Figure 3 4: Global – Contract Research & Manufacturing Market (in Billion US$), 2009 – 2012
Figure 3 5: Global – Contract Research & Manufacturing Market Forecast (in Billion US$), 2013 – 2018
Figure 3 6: Estimated Costs incurred in Various Pharmaceutical Operations
Figure 4 1: Global – Healthcare Cold Chain Products Market – Break up by Product (in %), 2005 – 2012
Figure 4 2: Global – Healthcare Cold Chain Products Market Forecast – Break up by Product (in %), 2013 – 2018
Figure 4 3: Global – Biopharmaceutical Market (in Billion US$), 2005 – 2012
Figure 4 4: Global – Biopharmaceutical Market Forecast (in Billion US$), 2013 – 2018
Figure 4 5: US & Europe – Biosimilar Sales & Forecast (in Million US$), 2008 – 2018
Figure 4 6: Global – Share of Biopharmaceutical Manufacturers Outsourcing Some Production to Contract Manufacturers (in %), 2006 & 2011
Figure 4 7: Global – Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2011 & 2012
Figure 4 8: Global – Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2013 – 2018
Figure 4 9: Global – Vaccine Market (in Billion US$), 2005 – 2012
Figure 4 10: Global – Vaccine Market Forecast (in Billion US$), 2013 – 2018
Figure 4 11: Global – Vaccine Production Volume by Region (in %), 2008*
Figure 4 12: Europe – Vaccine Export Volume by Region (in %), 2008*
Figure 4 13: Global – Clinical Trials Market (in Billion US$), 2005 – 2012
Figure 4 14: Global – Clinical Trials Market – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009 – 2012
Figure 4 15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982 – 2009
Figure 4 16: Global – Clinical Trials Market Forecast (in Billion US$), 2013 – 2018
Figure 4 17: Global – Clinical Trials Market Forecast – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2013 – 2018
Figure 4 18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global Pharmaceutical Companies*
Figure 4 19: Global – Breakup of Biopharmaceuticals & Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
Figure 4 20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
Figure 5 1: A Typical Drug Supply Chain from the Manufacturer to the End User
Figure 6 1: Global – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2002 – 2012
Figure 6 2: Global -Healthcare Cold Chain Packaging & Instrumentation Services Market (in Billion US$), 2002 – 2012
Figure 6 3: Global – Healthcare Cold Chain Logistic Services Market by Region (in %), 2009, 2012, 2015 & 2018
Figure 6 4: North America – Healthcare Cold Chain Logistic Services Market – (in Billion US$), 2008 – 2012
Figure 6 5: North America – Healthcare Cold Chain Logistic Services Market Forecast – (in Billion US$), 2013 – 2018
Figure 6 6: Europe – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2012
Figure 6 7: Europe – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2013 – 2018
Figure 6 8: Asia Pacific – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2012
Figure 6 9: Asia Pacific – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2013 – 2018
Figure 6 10: Rest of the World – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2012
Figure 6 11: Rest of the World – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2013 – 2018
Figure 7 1: Financing Sources and Gaps (in %), 2008 – 2010

List of  Tables

Table 3 1: Various Regulations on Healthcare Cold Chain Logistic Requirements
Table 4 1: Global – Healthcare Cold Chain Products Market – Break up by Product (in Billion US$), 2005 – 2012
Table 4 2: Global – Healthcare Cold Chain Products Market Forecast – Break up by Product (in Billion US$), 2013 – 2018
Table 4 3: Global – Biopharmaceutical Market – Sales by Class (in Billion US$), 2005 – 2012
Table 4 4: Global – Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2013 – 2018
Table 4 5: Stability of Various Biopharmaceuticals at Room Temperature
Table 4 6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 4 7: Temperature Stability of Commonly Used Vaccines
Table 4 8: The Effect of Temperature Excursions on the Usability of Vaccines
Table 4 9: Global – Major Vaccine Production Sites (in Numbers), 2008*
Table 4 10: Ideal Storage Temperatures for Clinical Trial Materials
Table 5 1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
Table 5 2: Dry Ice Containers
Table 5 3: Refrigerated Shipping Containers with Gel Packs
Table 5 4 : Costs Associated With the Cold Chain Shipment of Healthcare Products, 2013*
Table 5 5 : Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2013*
Table 7 1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008 – 2010


To buy the complete report or to get a free sample, please contact:


IMARC Group Asia

Email: [email protected]

Phone: +91-120-415-5099

IMARC Group North America

Email:  [email protected]

Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa

Email:[email protected]

Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/healthcare-cold-chain-logistics-market/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: Send Email
Phone: +91-120-415-5099
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

  Categories: